Use of Nasal Pressure to Assess Inspiratory Effort Under Different Oxygen Treatments

NCT ID: NCT06970990

Last Updated: 2025-05-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-20

Study Completion Date

2025-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study was to investigate the effects of different oxygen therapy modalities (including nasal cannula oxygen, mask oxygen and high-flow nasal cannula oxygen) on the correlation between Nasal Pressure and Esophageal Pressure by means of a prospective physiological study, to assess the dynamic changes of nasal pressure and esophageal pressure and their underlying mechanisms under different conditions of oxygen therapy, to analyse the effects of oxygen therapy parameters on the relationship between the two, and to explore the feasibility of nasal pressure as a non-invasive monitoring indicator, in order to replaceor supplement esophageal manometry in clinical practice, especially in patients with respiratory distress and instability.Meanwhile, this study will also evaluate the effects of different oxygen therapy modalities on patients' respiratory mechanics and comfort, provide a scientific basis for the clinical selection of individualised oxygen therapy regimens, and ultimately provide new physiological evidence for the management of oxygen therapy in patients with acute respiratory failure in the intensive care unit (ICU) and outside the ICU, promote the development of non-invasive monitoring technology, and improve the clinical prognosis and therapeutic experience of patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients in the intensive care unit (ICU) often require different modalities of oxygen therapy to maintain adequate oxygenation.Common oxygen therapy modalities include nasal cannula oxygen, face mask oxygen and high flow nasal cannula oxygen (HFNC).These modalities of oxygen therapy not only affect the patient's oxygenation status, but may also influence nasal and esophageal pressures by altering the upper airway pressure gradient, which in turn affects respiratory mechanics and patient comfort.

Esophageal pressure fluctuations (ΔPes), as a reflection of mean transpulmonary pressure during unassisted voluntary breathing, provide an important basis for assessing inspiratory effort.However, esophageal manometry still faces many challenges for its bedside implementation in clinical practice, especially in unstable patients with respiratory distress and severely impaired gas exchange.Notably, the COVID-19 pandemic has led to a significant increase in the number of patients with acute respiratory failure, who often require condition-specific oxygen therapy of varying severity and are mostly treated outside the ICU.Given that such patients are at high risk of deterioration, it is particularly important to continuously monitor their inspiratory effort.

nasal pressure is an important physiological indicator for assessing upper airway resistance and airflow dynamics characteristics, whereas esophageal pressure is a key parameter that directly reflects intrathoracic pressure and respiratory effort.Previous studies have shown that there may be a physiological correlation between intranasal pressure and oesophageal pressure, and that this correlation may be influenced by a variety of factors, including airflow velocity, oxygen concentration, and the dynamics of upper airway resistance.Earlier physiological studies by comparing oesophageal pressure fluctuations (ΔPes) with nasal pressure fluctuations (ΔPnose) fluctuations found that when inspiratory effort was increased, there was no significant phase difference between these pressure waveforms.In addition, it was observed that there was a significant correlation between ΔPes and airway pressure fluctuations (ΔPaw) obtained by airway occlusion manoeuvres during inspiratory effort testing.However, although these findings provide important clues for understanding respiratory mechanics, studies on the correlation between nasal pressure and esophageal pressure under different oxygen therapy conditions are still relatively limited, especially lacking data support from prospective physiological studies.Therefore, further systematic studies are needed in the future to investigate in depth the effects of different oxygen therapy parameters (e.g., flow rate, humidity, and temperature, etc.) on the relationship between nasal pressure and esophageal pressure, so as to provide more precise guidance for clinical practice.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critical Care Inspiratory Effort

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HFNC:flow=50L/min

Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes

Group Type EXPERIMENTAL

HFNC:50L/min

Intervention Type PROCEDURE

Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes

HFNC:flow=40L/min

Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes

Group Type EXPERIMENTAL

HFNC:flow=40L/min

Intervention Type PROCEDURE

Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes.

HFNC:flow=30L/min

Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes

Group Type EXPERIMENTAL

HFNC:flow=30L/min

Intervention Type PROCEDURE

Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes.

Face Mask Oxygen:8L/min

Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.

Group Type EXPERIMENTAL

Face mask oxygen:8L/min

Intervention Type PROCEDURE

Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.

Face Mask Oxygen:5L/min

Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Group Type EXPERIMENTAL

Face mask oxygen:5L/min

Intervention Type PROCEDURE

Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Nasal cannula oxygen:5L/min

Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Group Type EXPERIMENTAL

Nasal cannula oxygen:5L/min

Intervention Type PROCEDURE

Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Nasal cannula oxygen:3L/min

Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.

Group Type EXPERIMENTAL

Nasal cannula oxygen:3L/min

Intervention Type PROCEDURE

Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HFNC:flow=40L/min

Under high-flow oxygen therapy at a flow rate of 40 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

HFNC:flow=30L/min

Under high-flow oxygen therapy at a flow rate of 30 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

Face mask oxygen:8L/min

Under face mask oxygen at a flow rate of 8 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

Face mask oxygen:5L/min

Under face mask oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

Nasal cannula oxygen:5L/min

Under nasal cannula oxygen at a flow rate of 5 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

Nasal cannula oxygen:3L/min

Under nasal cannula oxygen at a flow rate of 3 L/min, record/monitor for 5 minutes.

Intervention Type PROCEDURE

HFNC:50L/min

Under high-flow oxygen therapy at a flow rate of 50 L/min, record/monitor for 5 minutes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. No mechanical ventilation required,Able to tolerate oxygen therapy via nasal cannula, standard face mask, or nasal high-flow oxygen therapy;
2. Respiratory stability:Capable of spontaneous breathing with effective cough for secretion clearance.Oxygen saturation (SpO₂) \> 90% or PaO₂/FiO₂ ≥ 150 mmHg when receiving nasal cannula oxygen at 3 L/min;
3. Hemodynamic stability:Heart rate (HR) ≤ 120 bpm;Systolic blood pressure (SBP) 90-150 mmHg;No vasoactive medications OR norepinephrine dosage \< 0.1-0.2 μg/kg·min (or equivalent doses of other vasoactive agents);
4. Metabolic stability;
5. Compliance with medical instructions.Able to follow prescribed tasks.Esophageal pressure monitoring catheter already in place;
6. Patient or legal guardian agrees to participate and has signed the informed consent form.

Exclusion Criteria

1. Age \< 18 years;
2. Pregnancy;
3. Hemodynamic instability:Mean arterial pressure (MAP) \< 60 mmHg.Heart rate (HR) \> 120 bpm or \< 60 bpm;
4. Respiratory instability:Respiratory rate (RR) \> 35 bpm.Oxygen saturation (SpO₂) \< 90%;
5. Neuromuscular diseases or phrenic nerve injury;
6. Recent trauma or surgery involving the trachea, esophagus, neck, or chest.Contraindications to esophageal catheter placement or inability to monitor esophageal pressure;
7. Nasal obstruction or anatomical abnormalities:Complete nasal obstruction.Severe anatomical abnormalities (e.g., severe septal deviation, nasal polyps, or tumors) preventing catheter placement or compromising ventilation;
8. High-risk craniofacial conditions:Severe facial trauma or skull base fracture with risk of catheter misplacement into the intracranial space.Active epistaxis or incomplete healing after nasal surgery;
9. Bleeding risk:Severe coagulopathy.Esophageal/gastric varices or other conditions predisposing to hemorrhage.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jian-Xin Zhou

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jian-Xin Zhou

Head of Emergency and Critical Care Center

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jian-Xin Zhou, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Capital Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Shijitan Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jian-Xin Zhou, MD, PhD

Role: CONTACT

8610 6392 6666

Rui-Zhi Zhang,MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jian-Xin Zhou, MD, PhD

Role: primary

+861063926666

Rui-Zhi Zhang,MD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IIT2025-031-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.